{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:23:02Z","timestamp":1757704982421,"version":"3.41.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T00:00:00Z","timestamp":1450483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00392-015-0950-0","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T14:52:54Z","timestamp":1450536774000},"page":"527-534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["\u03b2-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index"],"prefix":"10.1007","volume":"105","author":[{"given":"Ulrich","family":"Fischer-Rasokat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Honold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Lochmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Liebetrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Fichtlscherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helge","family":"M\u00f6llmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioakim","family":"Spyridopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian W.","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,19]]},"reference":[{"issue":"13","key":"950_CR1","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","volume":"308","author":"S Bangalore","year":"2012","unstructured":"Bangalore S, Steg G, Deedwania P et al (2012) \u03b2-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 308(13):1340\u20131349","journal-title":"JAMA"},{"issue":"2","key":"950_CR2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ijcard.2012.10.001","volume":"168","author":"N Ozasa","year":"2013","unstructured":"Ozasa N, Morimoto T, Bao B et al (2013) \u03b2-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure. Int J Cardiol 168(2):774\u2013779","journal-title":"Int J Cardiol"},{"issue":"6","key":"950_CR3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCOUTCOMES.114.001073","volume":"7","author":"S Bangalore","year":"2014","unstructured":"Bangalore S, Bhatt DL, Steg PG et al (2014) \u03b2-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA Trial. Circ Cardiovasc Qual Outcomes 7(6):872\u2013881","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"950_CR4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2009.02.088","volume":"54","author":"B Williams","year":"2009","unstructured":"Williams B, Lacy PS (2009) Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (conduit artery function evaluation) study: CAFE-heart rate. J Am Coll Cardiol 54(8):705\u2013713","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"950_CR5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MJT.0b013e3181758855","volume":"15","author":"JS Borer","year":"2008","unstructured":"Borer JS, Le Heuzey JY (2008) Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor. Am J Ther 15(5):461\u2013473","journal-title":"Am J Ther"},{"key":"950_CR6","unstructured":"Vilaine JP (2006) The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease. Pharmacol Res Offi J Ital Pharmacol Soc 53(5):424\u2013434"},{"issue":"2","key":"950_CR7","doi-asserted-by":"crossref","first-page":"H676","DOI":"10.1152\/ajpheart.00564.2002","volume":"284","author":"P Colin","year":"2003","unstructured":"Colin P, Ghaleh B, Monnet X et al (2003) Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol 284(2):H676\u2013H682","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"950_CR8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/HYPERTENSIONAHA.111.183913","volume":"59","author":"PM Becher","year":"2012","unstructured":"Becher PM, Lindner D, Miteva K et al (2012) Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and beta-receptor blockade. Hypertension 59(5):949\u2013957","journal-title":"Hypertension"},{"issue":"15","key":"950_CR9","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jacc.2013.06.043","volume":"62","author":"W Kosmala","year":"2013","unstructured":"Kosmala W, Holland DJ, Rojek A et al (2013) Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial. J Am Coll Cardiol 62(15):1330\u20131338","journal-title":"J Am Coll Cardiol"},{"key":"950_CR10","volume-title":"Principles of exercise testing and interpretation","author":"K Wasserman","year":"2005","unstructured":"Wasserman K, Hansen JE, Sue DY et al (2005) Principles of exercise testing and interpretation, 4th edn. Lippincott Williams & Williams, Philadelphia","edition":"4"},{"issue":"2","key":"950_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","volume":"10","author":"SF Nagueh","year":"2009","unstructured":"Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10(2):165\u2013193","journal-title":"Eur J Echocardiogr"},{"key":"950_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2015.03.313","volume":"187","author":"EN Simantirakis","year":"2015","unstructured":"Simantirakis EN, Nakou ES, Kallergis EM et al (2015) Long-term effect of If-channel inhibition on diastolic function and exercise capacity in heart failure patients with preserved ejection fraction. Int J Cardiol 187:9\u201311","journal-title":"Int J Cardiol"},{"issue":"9","key":"950_CR13","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","volume":"113","author":"B Williams","year":"2006","unstructured":"Williams B, Lacy PS, Thom SM et al (2006) Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113(9):1213\u20131225","journal-title":"Circulation"},{"issue":"4","key":"950_CR14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/08037059309077169","volume":"2","author":"LH Missault","year":"1993","unstructured":"Missault LH, Duprez DA, Brandt AA et al (1993) Exercise performance and diastolic filling in essential hypertension. Blood Press 2(4):284\u2013288","journal-title":"Blood Press"},{"issue":"7","key":"950_CR15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0895-7061(03)00842-2","volume":"16","author":"HK Kim","year":"2003","unstructured":"Kim HK, Kim YJ, Cho YS et al (2003) Determinants of exercise capacity in hypertensive patients: new insights from tissue Doppler echocardiography. Am J Hypertens 16(7):564\u2013569","journal-title":"Am J Hypertens"},{"issue":"6","key":"950_CR16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00004872-200206000-00037","volume":"20","author":"E Gerdts","year":"2002","unstructured":"Gerdts E, Bjornstad H, Toft S et al (2002) Impact of diastolic Doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). J Hypertens 20(6):1223\u20131229","journal-title":"J Hypertens"},{"key":"950_CR17","doi-asserted-by":"crossref","unstructured":"Lin FY, Zemedkun M, Dunning A et al (2013) Extent and severity of coronary artery disease by coronary CT angiography is associated with elevated left ventricular diastolic pressures and worsening diastolic function. Journal of cardiovascular computed tomography 7(5):289\u201396 e1","DOI":"10.1016\/j.jcct.2013.08.008"},{"issue":"2","key":"950_CR18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijcard.2007.06.003","volume":"127","author":"Y Neuman","year":"2008","unstructured":"Neuman Y, Kotliroff A, Bental T et al (2008) Pulmonary artery pressure and diastolic dysfunction in normal left ventricular systolic function. Int J Cardiol 127(2):174\u2013178","journal-title":"Int J Cardiol"},{"issue":"11","key":"950_CR19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00392-013-0594-x","volume":"102","author":"M Ciurzynski","year":"2013","unstructured":"Ciurzynski M, Bienias P, Irzyk K et al (2013) Exaggerated increase of exercise-induced pulmonary artery pressure in systemic sclerosis patients predominantly results from left ventricular diastolic dysfunction. Clin Res Cardiol 102(11):813\u2013820","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"950_CR20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","volume":"3","author":"BA Borlaug","year":"2010","unstructured":"Borlaug BA, Nishimura RA, Sorajja P et al (2010) Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Failure 3(5):588\u2013595","journal-title":"Circ Heart Failure"},{"issue":"36","key":"950_CR21","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/eurheartj\/ehs218","volume":"34","author":"JC Reil","year":"2013","unstructured":"Reil JC, Hohl M, Reil GH et al (2013) Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction. Eur Heart J 34(36):2839\u20132849","journal-title":"Eur Heart J"},{"issue":"4","key":"950_CR22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bjp.2008.116","volume":"154","author":"A Drouin","year":"2008","unstructured":"Drouin A, Gendron ME, Thorin E et al (2008) Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice. Br J Pharmacol 154(4):749\u2013757","journal-title":"Br J Pharmacol"},{"issue":"18","key":"950_CR23","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.107.746537","volume":"117","author":"F Custodis","year":"2008","unstructured":"Custodis F, Baumhakel M, Schlimmer N et al (2008) Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 117(18):2377\u20132387","journal-title":"Circulation"},{"issue":"6","key":"950_CR24","doi-asserted-by":"crossref","first-page":"e39394","DOI":"10.1371\/journal.pone.0039394","volume":"7","author":"L Yue-Chun","year":"2012","unstructured":"Yue-Chun L, Teng Z, Na-Dan Z et al (2012) Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis. PLoS One 7(6):e39394","journal-title":"PLoS One"},{"issue":"3","key":"950_CR25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000322905","volume":"117","author":"D Busseuil","year":"2010","unstructured":"Busseuil D, Shi Y, Mecteau M et al (2010) Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis. Cardiology 117(3):234\u2013242","journal-title":"Cardiology"},{"key":"950_CR26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yjmcc.2014.03.001","volume":"73","author":"AC Kohler","year":"2014","unstructured":"Kohler AC, Sag CM, Maier LS (2014) Reactive oxygen species and excitation-contraction coupling in the context of cardiac pathology. J Mol Cell Cardiol 73:92\u2013102","journal-title":"J Mol Cell Cardiol"},{"issue":"38","key":"950_CR27","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/eurheartj\/ehv305","volume":"36","author":"T Munzel","year":"2015","unstructured":"Munzel T, Gori T, Keaney JF Jr et al (2015) Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. Eur Heart J 36(38):2555\u20132564","journal-title":"Eur Heart J"},{"issue":"18","key":"950_CR28","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehn337","volume":"29","author":"G Heusch","year":"2008","unstructured":"Heusch G, Skyschally A, Gres P et al (2008) Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. Eur Heart J 29(18):2265\u20132275","journal-title":"Eur Heart J"},{"issue":"17","key":"950_CR29","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1111\/bph.13220","volume":"172","author":"P Kleinbongard","year":"2015","unstructured":"Kleinbongard P, Gedik N, Witting P et al (2015) Pleiotropic, heart rate-independent cardioprotection by ivabradine. Br J Pharmacol 172(17):4380\u20134390","journal-title":"Br J Pharmacol"},{"issue":"6","key":"950_CR30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00392-014-0679-1","volume":"103","author":"U Fischer-Rasokat","year":"2014","unstructured":"Fischer-Rasokat U, Honold J, Lochmann D et al (2014) Ivabradine therapy to unmask heart rate-independent effects of \u03b2-blockers on pulse wave reflections. Clin Res Cardiol 103(6):487\u2013494","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"950_CR31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0022-3565(25)12114-9","volume":"275","author":"L Simon","year":"1995","unstructured":"Simon L, Ghaleh B, Puybasset L et al (1995) Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 275(2):659\u2013666","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"950_CR32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.CIR.101.6.689","volume":"101","author":"G Heusch","year":"2000","unstructured":"Heusch G, Baumgart D, Camici P et al (2000) \u03b1-adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation 101(6):689\u2013694","journal-title":"Circulation"},{"issue":"3","key":"950_CR33","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1152\/jappl.1997.82.3.908","volume":"82","author":"WW Stringer","year":"1997","unstructured":"Stringer WW, Hansen JE, Wasserman K (1997) Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol 82(3):908\u2013912","journal-title":"J Appl Physiol"},{"issue":"6","key":"950_CR34","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1152\/jappl.1996.81.6.2674","volume":"81","author":"BJ Whipp","year":"1996","unstructured":"Whipp BJ, Higgenbotham MB, Cobb FC (1996) Estimating exercise stroke volume from asymptotic oxygen pulse in humans. J Appl Physiol 81(6):2674\u20132679","journal-title":"J Appl Physiol"},{"issue":"3","key":"950_CR35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1378\/chest.121.3.841","volume":"121","author":"E Klainman","year":"2002","unstructured":"Klainman E, Fink G, Lebzelter J et al (2002) The relationship between left ventricular function assessed by multigated radionuclide test and cardiopulmonary exercise test in patients with ischemic heart disease. Chest 121(3):841\u2013845","journal-title":"Chest"},{"key":"950_CR36","author":"MP Sperling","year":"2014","unstructured":"Sperling MP, Caruso FC, Mendes RG, Dutra DB, Arakelian VM, Bonjorno JC, Catai AM, Arena R, Borghi-Silva A (2014) Relationship between non-invasive haemodynamic responses and cardiopulmonary exercise testing in patients with coronary artery disease. Clin Physiol Funct Imaging. doi: 10.1111\/cpf.12197","journal-title":"Clin Physiol Funct Imaging"},{"issue":"2","key":"950_CR37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ahj.2004.02.012","volume":"148","author":"PM Mottram","year":"2004","unstructured":"Mottram PM, Haluska BA, Marwick TH (2004) Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload. Am Heart J 148(2):365\u2013370","journal-title":"Am Heart J"},{"issue":"3","key":"950_CR38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jacc.2003.07.047","volume":"43","author":"PY Marie","year":"2004","unstructured":"Marie PY, Mertes PM, Hassan-Sebbag N et al (2004) Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers. J Am Coll Cardiol 43(3):353\u2013359","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"950_CR39","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0735-1097(98)00478-1","volume":"32","author":"A Luchner","year":"1998","unstructured":"Luchner A, Burnett JC Jr, Jougasaki M et al (1998) Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. J Am Coll Cardiol 32(7):1839\u20131844","journal-title":"J Am Coll Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-015-0950-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-015-0950-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-015-0950-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T21:42:51Z","timestamp":1748727771000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-015-0950-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,19]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1007\/s00392-015-0950-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"type":"print","value":"1861-0684"},{"type":"electronic","value":"1861-0692"}],"subject":[],"published":{"date-parts":[[2015,12,19]]}}}